HomeInsightsStock Comparison

Thyrocare Technologies Ltd vs Vimta Labs Ltd Stock Comparison

Thyrocare Technologies Ltd vs Vimta Labs Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Thyrocare Technologies Ltd is ₹ 1323 as of 01 Aug 15:30.
  • The P/E Ratio of Thyrocare Technologies Ltd changed from 29.6 on March 2020 to 39.4 on March 2025 . This represents a CAGR of 4.88% over 6 yearsThe P/E Ratio of Vimta Labs Ltd changed from 19.1 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Thyrocare Technologies Ltd changed from ₹ 2618 crore on March 2020 to ₹ 3604 crore on March 2025 . This represents a CAGR of 5.47% over 6 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 130.94 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Thyrocare Technologies Ltd for the Jun '25 is ₹ 197.93 crore as compare to the Mar '25 revenue of ₹ 191.75 crore. This represent the growth of 3.22% The revenue of Vimta Labs Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Thyrocare Technologies Ltd for the Jun '25 is ₹ 62.67 crore as compare to the Mar '25 ebitda of ₹ 61.66 crore. This represent the growth of 1.64% The ebitda of Vimta Labs Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Thyrocare Technologies Ltd changed from ₹ 17.25 crore to ₹ 38.29 crore over 9 quarters. This represents a CAGR of 42.53% The net profit of Vimta Labs Ltd changed from ₹ 12.2 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Thyrocare Technologies Ltd changed from 33.31 % on March 2020 to 116.18 % on March 2025 . This represents a CAGR of 23.15% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 6.61 % on March 2025 . This represents a CAGR of -20.48% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Thyrocare Technologies Ltd

  • Thyrocare Technologies Limited was incorporated in January, 2000.
  • The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
  • Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
  • The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).

About Vimta Labs Ltd

  • Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
  • Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

Thyrocare Technologies Ltd News Hub

News

Thyrocare Tech spurts as Q1 PAT jumps 61% YoY to Rs 39 cr

Profit before tax stood at Rs 50.48 crore in Q1 FY26, registering a growth of 50.46% from ...

Read more

24 Jul 2025 12:14

News

Thyrocare Technologies schedules board meeting

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

17 Jul 2025 10:16

News

Thyrocare Technologies to hold AGM

Thyrocare Technologies announced that the 25th Annual General Meeting(AGM) of the company ...

Read more

07 Jul 2025 17:23

News

Thyrocare Technologies allots 996 equity shares under ESOS

Thyrocare Technologies has allotted 996 equity shares under ESOS. With this allotment, the...

Read more

21 May 2025 13:19

News

Thyrocare Tech spurts as Q4 PAT jumps 22% YoY to Rs 22 cr; declares dividend of Rs 21/sh

Profit before tax (PBT) for the March quarter stood at Rs 47.19 crore, marking a robust 10...

Read more

24 Apr 2025 10:07

News

Board of Thyrocare Technologies recommends Final Dividend

Thyrocare Technologies announced that the Board of Directors of the Company at its meeting...

Read more

23 Apr 2025 16:32

Vimta Labs Ltd News Hub

News

Vimta Labs announces board meeting date

Vimta Labs will hold a meeting of the Board of Directors of the Company on 17 July 2025. P...

Read more

15 Jul 2025 09:58

News

Vimta Labs allots Equity Shares

Vimta Labs has approved the allotted 2,22,52,784 equity shares of Rs. 2/- each as fully-pa...

Read more

16 Jun 2025 10:39

News

Vimta Labs cancels board meeting

Vimta Labs has cancelled the board meeting which was scheduled to be held on 14 June 2025....

Read more

14 Jun 2025 09:55

News

Vimta Labs to conduct board meeting

Vimta Labs will hold a meeting of the Board of Directors of the Company on 14 June 2025. P...

Read more

07 Jun 2025 10:22

News

Vimta Labs allots 18,272 equity shares under ESOP

Vimta Labs has allotted 18,272 equity shares under ESOP on 23 May 2025. The paid-up share ...

Read more

23 May 2025 16:18

News

Vimta Labs to hold AGM

Vimta Labs announced that the 35th Annual General Meeting(AGM) of the company will be held...

Read more

17 May 2025 12:59

SWOT Analysis Of Thyrocare Technologies Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Vimta Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Thyrocare Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vimta Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Thyrocare Technologies Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Thyrocare Technologies Ltd or Vimta Labs Ltd?

Market cap of Thyrocare Technologies Ltd is 7,012 Cr while Market cap of Vimta Labs Ltd is 3,063 Cr

What are the key factors driving the stock performance of Thyrocare Technologies Ltd and Vimta Labs Ltd?

The stock performance of Thyrocare Technologies Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Thyrocare Technologies Ltd and Vimta Labs Ltd?

As of August 2, 2025, the Thyrocare Technologies Ltd stock price is INR ₹1323.3. On the other hand, Vimta Labs Ltd stock price is INR ₹688.45.

How do dividend payouts of Thyrocare Technologies Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Thyrocare Technologies Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions